Dr. Vinai Gondi, MD

Dr. Gondi practices at Northwestern Medical Group in Warrenville, Illinois.

Dr. Gondi's NPI, 1457516395, was assigned on July 21, 2008. Dr. Gondi graduated from Vagelos College of Physicians and Surgeons in 2007. Dr. Gondi holds Illinois license 036.130360.

Dr. Gondi's primary practice is Northwestern Medical Group, at 4405 Weaver Pkwy, Warrenville, IL 60555-3269. The practice phone is (630) 352-5450.

Dr. Gondi's primary practice is Northwestern Medical Group in Warrenville, Illinois. Dr. Gondi is also affiliated with Northwestern Medicine Central DuPage Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Gondi to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gondi practices, 7 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Gondi's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Gondi is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Gondi's licenses on file in 2 states: Illinois and Wisconsin.

Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, head & neck cancer radiation, lung cancer radiation and uterine cancer radiation among the conditions Dr. Gondi treats.

CMS data shows 2,357 Medicare services from Dr. Gondi across 20 procedure codes in 2024, for 480 Medicare patients. Medicare paid $214,463 for them. Every service was in an office.

CMS counts 480 Medicare patients who saw Dr. Gondi in 2024. The largest group is 65 to 74, with 242 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gondi's median patient age at 69, with 50% women.

In 2024, Dr. Gondi wrote 83 Medicare Part D claims for 55 patients. 98% of them were for generic drugs. CMS names the drug for 58 of them, across 2 drugs with 11 or more claims each, at $1,341 in total drug cost. In 2023, CMS named 69 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Gondi for performance year 2024, reported through an alternative payment model (APM). Dr. Gondi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gondi as offering telehealth.

Dmand AI links 84 papers to Dr. Gondi, published from 2010 to 2024. 2021 was the busiest year, with 10. The most frequent topics are Brain Neoplasms, Cranial Irradiation and Hippocampus. Dr. Gondi has published most often in Int J Radiat Oncol Biol Phys. Dr. Gondi's most frequent co-authors are Minesh P. Mehta, MD, Paul D. Brown, MD and Joshua D. Palmer, MD.

Dmand AI links Dr. Gondi to 4 clinical trials, 3 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Oligodendroglioma, Ependymoma and Neurotoxicity Syndromes. NRG Oncology sponsors the most, 2.

CMS Open Payments shows 37 general payments to Dr. Gondi from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Servier Pharmaceuticals LLC paid the most, $22,192.

Dr. Gondi graduated from Vagelos College of Physicians and Surgeons in 2007.

Dr. Gondi is in network with 17 carriers, including Aetna, HCSC and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.